Indeed, this group of diseases, which include polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF), is characterized by the uncontrolled clonal expansion of multipotent bone marrow progenitors driven by acquired mutations in the JAK2, CALR, and MPL genes [1]. The gene discussed is JAK2; the disease is myelofibrosis.